SKELETAL MUSCLE SENSITIVITY TO WASTING INDUCED BY UROTHELIAL CARCINOMA
DOI:
https://doi.org/10.15407/exp-oncology.2023.01.107Keywords:
collagen deposition, cross-sectional area, histology, myonuclear domain, сancerAbstract
Background: Skeletal muscle wasting is a common phenotypic feature of several types of cancer, and it is associated with functional impairment, respiratory complications, and fatigue. However, equivocal evidence remains regarding the impact of cancer-induced muscle wasting on the different fiber types. Aim: The aim of this study was to investigate the impact of urothelial carcinoma induced in mice on the histomorphometric features and collagen deposition in different skeletal muscles.Materials and Methods: Thirteen ICR (CD1) male mice were randomly assigned into two groups: exposed to 0.05% N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in drinking water for 12 weeks, plus 8 weeks of tap water (BBN, n = 8) or with access to tap water for 20 weeks (CONT, n = 5). Tibialis anterior, soleus, and diaphragm muscles were collected from all animals. For cross-sectional area and myonuclear domain analysis, muscle sections were stained with hematoxylin and eosin, and for collagen deposition assessment, muscle sections were stained with picrosirius red. Results: All animals from the BBN group developed urothelial preneoplastic and neoplastic lesions, and the tibialis anterior from these animals presented a reduced cross-sectional area (p < 0.001), with a decreased proportion of fibers with a higher cross-sectional area, increased collagen deposition (p = 0.017), and higher myonuclear domain (p = 0.031). BBN mice also showed a higher myonuclear domain in the diaphragm (p = 0.015). Conclusion: Urothelial carcinoma induced muscle wasting of the tibialis anterior, expressed by a decreased cross-sectional area, higher infiltration of fibrotic tissue, and increased myonuclear domain, which also increased in the diaphragm, suggesting that fast glycolytic muscle fibers are more susceptible to be affected by cancer development.
References
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424. doi: 10.3322/caac.21492
Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol 2019; 20: 1493–1505. doi: 10.1016/S1470-2045(19)30456-5
Fearon KC. Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 2008; 44: 1124–1132. doi: 10.1016/j.ejca.2008.02.033
Argiles JM, Busquets S, Stemmler B, et al. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 2014; 14: 754–762. doi: 10.1038/nrc3829
Eley HL, Tisdale MJ. Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. J Biol Chem 2007; 282: 7087–7097. doi: 10.1074/jbc.M610378200
Toledo M, Busquets S, Sirisi S, et al. Cancer cachexia: physical activity and muscle force in tumour-bearing rats. Oncol Rep 2011; 25: 189–193
Bower JE. Cancer-related fatigue–mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 2014; 11: 597–609. doi:10.1038/nrclinonc.2014.127
Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr 2014; 33: 737–748. doi:10.1016/j.clnu.2014.03.007
Hardee JP, Montalvo RN, Carson JA. Linking cancer cachexia-induced anabolic resistance to skeletal muscle oxidative metabolism. Oxid Med Cell Longev 2017; 2017: 8018197. doi: 10.1155/2017/8018197
Li YP, Chen Y, Li AS, et al. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 2003; 285: C806–C812. doi: 10.1152/ajpcell.00129.2003
Ott M, Gogvadze V, Orrenius S, et al. Mitochondria, oxidative stress and cell death. Apoptosis 2007; 12: 913–922. doi: 10.1007/s10495-007-0756-2
Yu Z, Li P, Zhang M, et al. Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli. PLoS One 2008; 3: e2086. doi:10.1371/journal.pone.0002086
Johns N, Hatakeyama S, Stephens NA, et al. Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle. PLoS One 2014; 9: e83618. doi: 10.1371/journal.pone.0083618
Julienne CM, Dumas JF, Goupille C, et al. Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency. J Cachexia Sarcopenia Muscle 2012; 3: 265–275. doi: 10.1007/s13539-012-0071-9
Acharyya S, Ladner KJ, Nelsen LL, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004; 114: 370–378. doi: 10.1172/JCI20174
Hiroux C, Dalle S, Koppo K, et al. Voluntary exercise does not improve muscular properties or functional capacity during C26-induced cancer cachexia in mice. J Muscle Res Cell Motil 2021; 42: 169–181. doi: 10.1007/s10974-021-09599-6
Aulino P, Berardi E, Cardillo VM, et al. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer 2010; 10: 363. doi: 10.1186/1471-2407-10-363
Monitto CL, Berkowitz D, Lee KM, et al. Differential gene expression in a murine model of cancer cachexia. Am J Physiol Endocrinol Metab 2001; 281: E289–E297. doi:10.1152/ajpendo.2001.281.2.E289
Marin-Corral J, Fontes CC, Pascual-Guardia S, et al. Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. Antioxid Redox Signal 2010; 12: 365–380. doi: 10.1089/ars.2009.2818
Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 2012; 16: 153–166. doi: 10.1016/j.cmet.2012.06.011
Li P, Waters RE, Redfern SI, et al. Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice. Am J Pathol 2007; 170: 599–608. doi: 10.2353/ajpath.2007.060505
Talmadge RJ, Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol (1985) 1993; 75: 2337–2340
Caiozzo VJ, Baker MJ, Baldwin KM. Novel transitions in MHC isoforms: separate and combined effects of thyroid hormone and mechanical unloading. J Appl Physiol (1985) 1998; 85: 2237–2248. doi: 10.1152/jappl.1998.85.6.2237
Vasconcelos-Nobrega C, Pinto-Leite R, Arantes-Rodrigues R, et al. In vivo and in vitro effects of RAD001 on bladder cancer. Urol Oncol 2013; 31: 1212–1221. doi: 10.1016/j.urolonc.2011.11.002
Ferreira R, Neuparth MJ, Nogueira-Ferreira R, et al. Exercise training impacts cardiac mitochondrial proteome remodeling in murine urothelial carcinoma. Int J Mol Sci 2018; 20. doi: 10.3390/ijms20010127
Oliveira PA, Vasconcelos-Nobrega C, Gil da Costa RM, et al. The N-butyl-N-4-hydroxybutyl nitrosamine mouse urinary bladder cancer model. Methods Mol Biol 2018; 1655: 155–167. doi: 10.1007/978-1-4939-7234-0_13
Oliveira PA, Gil da Costa RM, Vasconcelos-Nobrega C, et al. Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery. Expert Opin Drug Discov 2016; 11: 599–607. doi: 10.1080/17460441.2016.1174690
Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435–1448. doi: 10.1097/00000478-199812000-00001
Bovolini A, Garcia J, Andrade MA, et al. Relative contribution of fat diet and physical inactivity to the development of metabolic syndrome and non-alcoholic fat liver disease in Wistar rats. Physiol Behav 2020; 225: 113040. doi: 10.1016/j.physbeh.2020.113040
Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489–495. doi: 10.1016/S1470-2045(10)70218-7
McGregor RA, Cameron-Smith D, Poppitt SD. It is not just muscle mass: a review of muscle quality, composition and metabolism during ageing as determinants of muscle function and mobility in later life. Longev Healthspan 2014; 3: 9. doi: 10.1186/2046-2395-3-9
Roberts BM, Frye GS, Ahn B, et al. Cancer cachexia decreases specific force and accelerates fatigue in limb muscle. Biochem Biophys Res Commun 2013; 435: 488–492. doi: 10.1016/j.bbrc.2013.05.018
Roberts BM, Ahn B, Smuder AJ, et al. Diaphragm and ventilatory dysfunction during cancer cachexia. FASEB J 2013; 27: 2600–2610. doi: 10.1096/fj.12-222844
Murphy KT, Chee A, Trieu J, et al. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis Model Mech 2012; 5: 533–545. doi: 10.1242/dmm.008839
Gransee HM, Mantilla CB, Sieck GC. Respiratory muscle plasticity. Compr Physiol 2012; 2: 1441–1462. doi: 10.1002/cphy.c110050
Aversa Z, Costelli P, Muscaritoli M. Cancer-induced muscle wasting: latest findings in prevention and treatment. Ther Adv Med Oncol 2017; 9: 369–382. doi: 10.1177/1758834017698643
Delaney K, Kasprzycka P, Ciemerych MA, et al. The role of TGF-beta1 during skeletal muscle regeneration. Cell Biol Int 2017; 41: 706–715. doi: 10.1002/cbin.10725
Lieber RL, Ward SR. Cellular mechanisms of tissue fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis. Am J Physiol Cell Physiol 2013; 305: C241–C252. doi: 10.1152/ajpcell.00173.2013
Judge SM, Nosacka RL, Delitto D, et al. Skeletal muscle fibrosis in pancreatic cancer patients with respect to survival. JNCI Cancer Spectr 2018; 2: pky043. doi: 10.1093/jncics/pky043
Mann CJ, Perdiguero E, Kharraz Y, et al. Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 2011; 1: 21. doi: 10.1186/2044-5040-1-21
Christov C, Chretien F, Abou-Khalil R, et al. Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 2007; 18: 1397–1409. doi: 10.1091/mbc.e06-08-0693
Pallafacchina G, Blaauw B, Schiaffino S. Role of satellite cells in muscle growth and maintenance of muscle mass. Nutr Metab Cardiovasc Dis 2013; 23 Suppl 1: S12–S18. doi: 10.1016/j.numecd.2012.02.002
Gibson MC, Schultz E. The distribution of satellite cells and their relationship to specific fiber types in soleus and extensor digitorum longus muscles. Anat Rec 1982; 202: 329–337. doi: 10.1002/ar.1092020305
Liu JX, Hoglund AS, Karlsson P, et al. Myonuclear domain size and myosin isoform expression in muscle fibres from mammals representing a 100,000-fold difference in body size. Exp Physiol 2009; 94: 117–129. doi: 10.1113/expphysiol.2008.043877
Dupont-Versteegden EE, Murphy RJ, Houle JD, et al. Activated satellite cells fail to restore myonuclear number in spinal cord transected and exercised rats. Am J Physiol 1999; 277: C589–C597. doi: 10.1152/ajpcell.1999.277.3.C589
Zhong H, Roy RR, Siengthai B, et al. Effects of inactivity on fiber size and myonuclear number in rat soleus muscle. J Appl Physiol (1985) 2005; 99: 1494–1499. doi: 10.1152/japplphysiol.00394.2005
Bruusgaard JC, Gundersen K. In vivo time-lapse microscopy reveals no loss of murine myonuclei during weeks of muscle atrophy. J Clin Invest 2008; 118: 1450–1457. doi: 10.1172/JCI34022
van Wessel T, de Haan A, van der Laarse WJ, et al. The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism? Eur J Appl Physiol 2010; 110: 665–694. doi: 10.1007/s00421-010-1545-0
Wang Y, Pessin JE. Mechanisms for fiber-type specificity of skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care 2013; 16: 243–250. doi: 10.1097/MCO.0b013e328360272d
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
